Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

• Published in: Journal of headache and pain Vol. 20; no. 1; pp. 118 - 2
• Main Authors: Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 27.12.2019; Springer Nature B.V; BMC
• Subjects: Correction; Internal Medicine; Medicine; Medicine & Public Health; Neurology; Pain Medicine

After publication of our article [1] we were notified that the data presented in the upper row of Fig. 7 was inadvertently the least square mean change from baseline (standard error) at Month 6 rather than the overall average of Month 3 and Month 6. The figure legend and discussion of the data in th...